Oral challenge in patients with suspected cutaneous adverse drug reactions: Findings in 784 patients during a 25-year-period

Acta Dermato-Venereologica

Volumn 85, Issue 6, 2005, Pages 491-496

  Lammintausta, Kaija ^a   Kortekangas Savolainen, Outi ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cutaneous adverse drug reaction; Drug hypersensitivity; Oral challenge

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMOXICILLIN; AMPICILLIN; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CAPTOPRIL; CARBAMAZEPINE; CEFADROXIL; CEFALEXIN; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; DILTIAZEM; GENTAMICIN; IBUPROFEN; KETOPROFEN; LANSOPRAZOLE; MACROLIDE; METRONIDAZOLE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN G; PHENAZONE DERIVATIVE; PHENYTOIN; SALAZOSULFAPYRIDINE; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

ARTICLE; CLINICAL EXAMINATION; CLINICAL PRACTICE; DIAGNOSTIC TEST; DRUG ERUPTION; DRUG HYPERSENSITIVITY; HUMAN; PRIORITY JOURNAL; RASH; SKIN MANIFESTATION; SKIN TEST;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ALLERGENS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; SKIN TESTS;

EID: 30644480179     PISSN: 08003831     EISSN: 16512057     Source Type: Journal    
DOI: 10.1080/00015550510042859     Document Type: Article

References (39)

1. Eaton L. Adverse reactions to drugs increase. BMJ 2002; 324: 8.
2. Lazarou J, Puneranz BH, Curey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
3. Hunziker T, Kunzi U, Braunschwei S, Zehnder D, Hoigne R. Comprehensive hospital drug monitoring: adverse drug reactions: a 20-year survey. Allergy 1997; 52: 388-393.
4. Lee CE, Zembower TR, Fotis MA, Postelnick MJ, Greenberger PA, Peterson LR, et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med 2000; 160: 2819-2822.
5. Fiszenson-Albala F, Auzerie V, Mahe E, Farinotti R, Durand-Stocco C, Crickx B, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003; 149: 1018-1022.
6. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity. Allergy 2003; 38: 854-863.
7. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005; 152: 968-974.
8. Lerch M, Pichler WJ. The immunological and clinical spectrum of delayed drug-induced exanthems. Curr Opin Allergy Clin Immunol 2004; 4: 411-419.
9. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004; 59: 809-820.
10. Alanko K, Stubb S, Kauppinen K. Cutaneous drug reactions: clinical types and causative agents. A five-year survey of in-patients (1981-1985). Acta Derm Venereol 1989; 69: 223-226.
11. Stubb S, Heikkilä H, Kauppinen K. Cutaneous reactions to drugs: a series of in-patients during a five-year period. Acta Derm Venereol 1994; 74: 289-294.
12. Leivo T, Heikkilä H. Naproxen-induced generalized bullous fixed drug eruption. Br J Dermatol 2004; 151: 232.
13. Mahboob A, Haroon TS. Drugs causing fixed drug eruptions: a study of 450 cases. Int J Dermatol 1998; 37: 833-838.
14. Swanbeck G, Dahlberg E. Cutaneous drug reactions. An attempt to quantitate estimation. Arch Dermatol Res 1992; 284: 215-218.
15. Naldi L, Conforti A, Venegoni M, Troncon MG, Caputi A, Ghiotto E, et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48: 839-846.
16. Solensky R. Drug desensitization. Immunol Allergy Clin North Am 2004; 24: 425-443.
17. Huang JL, Hung IJ, Chen LC, Lee WY, Hsueh C, Hsieh KH. Succesfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin. Clin Rheumatol 1998; 17: 349-352.
18. Finnish statistics on medicines 1980 to 1985. Helsinki, 1986.
19. Finnish statistics on medicines 1986 to 1987. Helsinki, 1988.
20. Finnish statistics on medicines 1999. Helsinki, 2000.
21. Salkind AR, Cuddy PG, Foxworth JW. The rational clinical examination. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. JAMA 2001; 285: 2498-2505.
22. Romano A, Quaratino D, Di Fonso M, Papa G, Venuti A, Gasbarrini G. A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins. J Allergy Clin Immunol 1999; 103: 1186-1190.
23. Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr 1998; 132: 137-143.
24. Macy E, Burchette RJ. Oral antibiotic adverse reactions after penicillin skin testing: multi-year follow-up. Allergy 2002; 57: 1151-1158.
25. Demoly P, Benahmed S, Valembois M, Sahla H, Messaad D, Godard P, et al. Allergy to macrolide antibiotics. Review of the literature. Presse Med 2000; 19: 321-326.
26. Kruppa A, Scharffetter-Kochaneck K, Krieg T, Hunzelmann N. Immediate reaction to roxitromycin and prick test cross-sensitization to erythromycin and clarithromycin. Dermatology 1998; 196: 335-336.
27. Brumfitt W, Hamilton-Miller JM. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. Antimicrob Chemother 1998; 42: 363-371.
28. Zitt JZ, Pawlak WA Jr. Drug reference manual. New York: Parthenon Publishing Group, 1997.
29. Campi P, Pichler WJ. Quinolone hypersensitivity. Curr Opin Allergy Clin Immunol 2003; 3: 275-281.
30. Lammintausta K, Tokola R, Kalimo K. Cutaneous adverse reactions to clindamycin: results of skin tests and oral exposure. Br J Dermatol 2002; 146: 1-6.
31. Hari Y, Frutig-Schnyder K, Hurni M, Yawalkar N, Zanni MP, Schnyder B, et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001; 31: 1398-1408.
32. Alanko K, Stubb S, Reitamo S. Topical provocation of fixed drug eruption. Br J Dermatol 1987; 116: 561-567.
33. Di Lorenzo G, Pacor ML, Vignola AM, Profita M, Esposito-Pellitteri M, Biasi D, et al. Urinary metabolites of histamine and leucotrienes before and after placebo-controlled challenge with ASA and food additives in chronic urticaria patients. Allergy 2002; 57: 1180-1186.
34. Onardo MM, Loconsole F, Rantuccio F. Conjugal allergic contact dermatitis from ketoprofen. Contact Dermatitis 1994; 30: 110.
35. Mahboob A, Haroon TS. Drugs causing fixed drug eruptions: a study of 450 cases. Int J Dermatol 1998; 37: 833-838.
36. Galindo PA, Borja J, Gomez E, Mur P, Gudin M, Garcia R, et al. Anticonvulsant drug hypersensitivity. J Invest Allergol Clin Immunol 2002; 12: 299-304.
37. Naisbitt DJ, Farrell J, Wong G, Depta PJH, Dodd CC, Hopkins JE, et al. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol 2003; 111: 1393-1403.
38. Gaig P, Miguel-Moncin MMS, Bartra J, Bonet A, Garcia-Ortega P. Usefulness of patch tests for diagnosing selective allergy to captopril. J Invest Allergol Clin Immunol 2001; 11: 204-206.
39. Cholez C, Trechot P, Schmutz JL, Faure G, Bene MC, Barbaud A. Maculopapular rash induced by diltiazem: allergological investigations in patients and cross reactions between calcium channel blockers. Allergy 2003; 58: 1207-1209.